PRESS RELEASE published on 05/03/2023 at 22:05, 1 year 6 months ago Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/02/2023 at 23:15, 1 year 6 months ago Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines
PRESS RELEASE published on 04/20/2023 at 22:05, 1 year 6 months ago Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
PRESS RELEASE published on 04/20/2023 at 13:30, 1 year 6 months ago Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
PRESS RELEASE published on 04/16/2023 at 17:00, 1 year 6 months ago Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following C
PRESS RELEASE published on 04/11/2023 at 13:00, 1 year 6 months ago Moderna Announces Clinical and Program Updates at 4th Vaccines Day
PRESS RELEASE published on 04/06/2023 at 23:00, 1 year 7 months ago MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melan
PRESS RELEASE published on 03/30/2023 at 13:00, 1 year 7 months ago Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
PRESS RELEASE published on 03/24/2023 at 12:30, 1 year 7 months ago Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
PRESS RELEASE published on 03/23/2023 at 12:02, 1 year 7 months ago Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Published on 11/08/2024 at 15:00, 1 hour 6 minutes ago Hoverfly Technologies Promotes Steve Topping to Chief Operating Officer
Published on 11/08/2024 at 15:00, 1 hour 6 minutes ago The Biltmore Los Angeles Welcomes Matthias Kaiser as New General Manager
Published on 11/08/2024 at 15:00, 1 hour 6 minutes ago SustainableIT.org Joins COP29 To Champion Climate Solutions and Responsible AI in Baku, Azerbaijan
Published on 11/08/2024 at 15:00, 1 hour 6 minutes ago Sky Gold Hires Gaia Life Capital Inc for Media Services
Published on 11/08/2024 at 15:46, 20 minutes ago Original-Research: Koenig & Bauer AG (von Montega AG): Kaufen (zuvor: Halten)
Published on 11/08/2024 at 15:13, 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/08/2024 at 15:12, 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/08/2024 at 12:32, 3 hours 34 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 3 hours 34 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 3 hours 51 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 3 hours 51 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 8 hours 6 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
